Sign Up to like & get
recommendations!
0
Published in 2023 at "Xenobiotica"
DOI: 10.1080/00498254.2023.2179952
Abstract: Abstract The metabolism and pharmacokinetics of fasiglifam (TAK-875, 2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid), a selective free fatty acid receptor 1 (FFAR1)/GPR40 agonist, were studied following intravenous (5 mg/kg) and oral administration (10 and 50 mg/kg) to male and female Sprague…
read more here.
Keywords:
female rats;
rats following;
following oral;
tak 875 ... See more keywords